| | |
| Authors of "false news" may face jail under new Gambian law Friday, Jul 05, 2013 12:42 AM PDT  BANJUL (Reuters) - Gambia's parliament has made sweeping changes to the country's information law, introducing new legislation that threatens those who spread "false news" with 15 years in prison and $100,000 in fines. The government said the changes were needed to ensure stability and prevent "unpatriotic behaviour" but they are likely to deepen Gambia's reputation as one of West Africa's most repressive countries. The new punishments, which apply to anything that is published, were spelled out in the updated Information and Communications Act adopted late on Wednesday. ... Full Story | Top |
| EU approves Novartis eye drug for new use Thursday, Jul 04, 2013 11:18 PM PDT  ZURICH (Reuters) - Swiss drugmaker Novartis' eye drug Lucentis has been approved as a treatment for a further condition related to worsening eyesight by the European Union, adding to three other conditions for which it is already approved. The Basel-based drugmaker said the European Commission had granted approval for Lucentis to treat patients with visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia. Lucentis, which was first launched in 2006, is an important product for Novartis and had sales of $2.4 billion in 2012. ... Full Story | Top |
| Delay in Obamacare requirement puts onus on the honor system Thursday, Jul 04, 2013 10:34 PM PDT  By Sharon Begley NEW YORK (Reuters) - The Obama administration's move to delay a key element of healthcare reform has another, unintended, consequence: A crucial part of that reform will depend on consumers observing the honor system, with millions of dollars at stake. The U.S. government said on Tuesday it would postpone by a year the provision that employers with 50 or more workers provide them with health insurance; the delay is intended to let companies work out how they report their compliance to tax authorities. ... Full Story | Top |
| Study finds MERS virus has not yet reached pandemic potential Thursday, Jul 04, 2013 04:08 PM PDT By Kate Kelland LONDON (Reuters) - The Middle East coronavirus that has killed 40 people since emerging late last year has not yet reached pandemic potential and may simply die out, according to new estimates of how easily it is transmitted. In a study in The Lancet medical journal, researchers from France's Institut Pasteur in Paris analyzed data on Middle East respiratory syndrome (MERS) clusters and found its likelihood of developing into a SARS-like worldwide epidemic was low. ... Full Story | Top |
| 'Mandela vs. Mandela' family feud sinks to soap opera Thursday, Jul 04, 2013 12:29 PM PDT  By Yvonne Bell MTHATHA, South Africa (Reuters) - A feud between factions of Nelson Mandela's family descended into soap opera farce on Thursday when his grandson and heir, Mandla, accused relatives of adultery and milking the fame of the revered anti-apartheid leader. In a news conference broadcast live on TV that stunned South Africans, Mandla Mandela confirmed rumors that his young son, Zanethemba, was in fact the child of an illicit liaison between his brother Mbuso and Mandla's now ex-wife Anais Grimaud. ... Full Story | Top |
| FDA approves Orexo drug to treat opioid addiction Thursday, Jul 04, 2013 11:41 AM PDT By Toni Clarke (Reuters) - The U.S. Food and Drug Administration has approved Swedish drugmaker Orexo AB's drug to treat opioid addiction, the company said on Thursday, sending its shares up as much as 14.3 percent in Stockholm. The tablet, Zubsolv, dissolves under the tongue. It combines the drugs buprenorphine and naloxone and will compete with similar products, Subutex and Suboxone, made by Britain's Reckitt-Benckiser Group Plc. Orexo said its drug offers a benefit to patients over Suboxone because less is required to achieve the same effect. ... Full Story | Top |
| China probes pricing at drugmakers including GSK, Merck Thursday, Jul 04, 2013 11:24 AM PDT  By Kazunori Takada SHANGHAI (Reuters) - China's top economic planning agency is investigating costs and prices charged by drugmakers, including units of GlaxoSmithKline and Merck, as foreign firms come under pressure from Beijing over possible price-fixing. The move follows a separate probe into instant milk powder, which has already led to price cuts. The National Development and Reform Commission (NDRC) is surveying production costs and prices charged at multiple foreign and Chinese drug companies, according to a July 2 statement from the commission. ... Full Story | Top |
| Reported IVF success rates can be misleading: study Thursday, Jul 04, 2013 10:08 AM PDT By Genevra Pittman NEW YORK (Reuters Health) - Fertility centers are mandated to report the number of in vitro fertilization (IVF) cycles they perform, but a new study suggests those data may give some practices misleadingly high success rates. Researchers looked at a database maintained by the Society for Assisted Reproductive Technologies (SART) and found the proportion of cycles that were begun but had no reported final outcome - successful or unsuccessful - increased from 2005 to 2010. What's more, 13 U.S. ... Full Story | Top |
| People eat less after harder workouts: small study Thursday, Jul 04, 2013 07:06 AM PDT By Kerry Grens NEW YORK (Reuters Health) - High intensity workouts may curb people's appetite shortly afterward, according to a small study. The researchers found that overweight men ate about 200 fewer calories following a vigorous workout than after rest. Some studies have shown that high intensity exercise is tied to appetite suppression and changes in hormones that regulate hunger and fullness, and the new research found different effects on those hormones among the various exercise regimens. ... Full Story | Top |
| Three million Europeans catch infections in hospital annually Thursday, Jul 04, 2013 03:23 AM PDT  By Kate Kelland LONDON (Reuters) - On any given day, some 80,000 patients in Europe are fighting an infection they picked up in hospital, often while in intensive care, the EU's disease monitoring agency said in a survey published on Thursday. Although some of these infections can be treated easily, others - like the superbug MRSA and other drug-resistant bugs - can be fatal or affect patients' health very seriously, taking several months of costly hospital care and medication to beat. ... Full Story | Top |
|
No comments:
Post a Comment